Boccara 2005.
Study characteristics | ||
Methods | Study design: parallel‐group randomized controlled trial Sample size: 48 Country: France Setting: secondary care Dates conducted: not reported Postoperative opioid used and delivery: nalbuphine Pain score collection: not reported Concurrent postoperative analgesics: paracetamol |
|
Participants |
Inclusion criteria
Exclusion criteria
|
|
Interventions |
Group K1 (24 participants): IV ketoprofen 100 mg before induction and IV saline end of surgery and continued for 24 hours Group K2 (24 participants): IV saline before induction and IV ketoprofen 100 mg end of surgery and continued for 24 hours |
|
Outcomes |
|
|
Notes | Funding: none reported Declarations of interest: not reported Authors contacted: yes Other: pain score converted to 0‐10 scale, pain score data extracted from graph and taken from one hour to allow postoperative dosing to take effect. Authors contacted for raw patient satisfaction data | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Computer‐generated. Quote: "computer‐generated random list" |
Allocation concealment (selection bias) | Unclear risk | No mention |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Double‐dummy placebo used. Quote: "in group K1, ketoprofen was administered before induction and saline after surgery". |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Blinded. Quote: "none of the patients, managing anaesthetists or nurses were aware of the randomization code". |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Exclusions unlikely to bias as equal in number. Quote: "Six patients were excluded from postoperative data analysis because four needed intraoperative laparotomy (one in K1, one in K2 and two in P1) and two for incomplete data (one in K1 and one in K2)". |
Selective reporting (reporting bias) | Unclear risk | No protocol or trial registration |
Other bias | High risk | More females in K2 group (Gerbershagen 2014) |